A patient in China with hepatocellular carcinoma survived 171 days following xenotransplantation with a genetically modified pig liver, the first evidence of the procedure’s feasibility in a living ...
The Chosun Ilbo on MSN
Gene-edited pig liver device bridges patient to transplant
The liver of a 56-year-old male patient was severely damaged. Suffering from chronic hepatitis B and heavy alcohol consumption, he developed severe liver failure. Without a transplant, survival was ...
Scientists in China achieve the first successful liver support therapy using ex vivo perfusion and a gene-edited pig.
More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...
More than 10,000 Americans are waiting for a liver transplant. Many more never make the list, because they are too sick to ...
The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...
GSK and Alfasigma have signed a licensing agreement granting Alfasigma worldwide exclusive rights to develop, manufacture and commercialise linerixibat, an investigational IBAT inhibitor for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results